real-world car-t outcomes, use of ide-cel, cilta-cel for myeloma
Published 1 year ago • 334 plays • Length 7:55Download video MP4
Download video MP3
Similar videos
-
1:38
real world use of car t-cell therapy in multiple myeloma
-
6:17
myeloma panel compares real-world versus clinical trial data for car-ts, bispecifics
-
4:34
what is the future for car-t in multiple myeloma?
-
2:14
is experience with ide-cel car-t in the real-world setting comparable to the karmma trial results?
-
13:36
real-world patient cases: car t-cell therapy
-
5:03
panelists discuss access to car-t for patients with myeloma
-
52:45
car t-cell therapy in multiple myeloma
-
4:14
challenges with the real-world use of car-t therapy in multiple myeloma
-
4:17
car-t cell therapy cilta-cel for relapsed/refractory myeloma | doris hansen, md | asco 2023
-
2:35
latest advances in car-t for multiple myeloma: cilta-cel & new car-t platforms
-
1:15
how do car-t cells kill myeloma cells?
-
5:56
advances in car-t therapy for r/r multiple myeloma: ide-cel & cilta-cel
-
47:11
asco/eha 2023 special: updates on car t-cell therapy in myeloma
-
5:19
bcma-targeted car-ts and their role in late-relapse multiple myeloma
-
55:08
real-world car-t data update
-
0:49
car-t therapy - myeloma australia - my life
-
1:51
analyzing real-world data for car t-cell therapy in patients with all and dlbcl
-
2:43
where does car-t fit in the myeloma treatment algorithm?
-
0:52
car-t cell therapy: it's astonishing